TCRαβ+ CD4−/CD8– “double negative” T cells in health and disease—implications for the kidney
Authors:
- 9 April 2022
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 102 (1) , 25-37
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Mechanistic Target of Rapamycin Activation Triggers IL-4 Production and Necrotic Death of Double-Negative T Cells in Patients with Systemic Lupus ErythematosusThe Journal of Immunology, 2013
- Immunoregulatory CD4-CD8- T cells as a potential therapeutic tool for transplantation, autoimmunity, and cancerFrontiers in Immunology, 2013
- Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directionsJournal of Molecular Cell Biology, 2012
- Anti-leukemia effect of ex vivo expanded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapyLeukemia, 2011
- Cutting Edge: IL-23 Receptor Deficiency Prevents the Development of Lupus Nephritis in C57BL/6– lpr/lpr MiceThe Journal of Immunology, 2010
- The effect of murine anti-thymocyte globulin on experimental kidney warm ischemia–reperfusion injury in miceTransplant Immunology, 2009
- The Role of IL-23/IL-17 Axis in Lupus NephritisThe Journal of Immunology, 2009
- Characterization of MHC class-I restricted TCRαβ+ CD4− CD8− double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccinationCancer Immunology, Immunotherapy, 2008
- Normal mouse kidneys contain activated and CD3+CD4−CD8− double-negative T lymphocytes with a distinct TCR repertoireJournal of Leukocyte Biology, 2008
- Cerebral leucocyte infiltration in lupus-prone MRL/MpJ-faslpr mice − roles of intercellular adhesion molecule-1 and P-selectinClinical and Experimental Immunology, 2006